Osaic Holdings
FATE icon

Osaic Holdings’s Fate Therapeutics FATE Stock Holding History

Osaic Holdings’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74K Hold
645
– – ﹤0.01% 7318
2026
Q1 		$774 Hold
645
– – ﹤0.01% 7334
2025
Q4 		$631 Sell
645
-2,140
-77% -$2.57K ﹤0.01% 7395
2025
Q3 		$3.11K Sell
2,785
-600
-18% -$647 ﹤0.01% 6984
2025
Q2 		$3.79K Buy
3,385
+1,180
+54% +$1.37K ﹤0.01% 6694
2025
Q1 		$1.74K Sell
2,205
-1,105
-33% -$1.35K ﹤0.01% 6652
2024
Q4 		$5.46K Buy
3,310
+98
+3% +$247 ﹤0.01% 6142
2024
Q3 		$11.2K Sell
3,212
-1,712
-35% -$6.66K ﹤0.01% 5749
2024
Q2 		$16.2K Sell
4,924
-31
-0.6% -$136 ﹤0.01% 5486
2024
Q1 		$36.4K Buy
4,955
+102
+2% +$631 ﹤0.01% 4958
2023
Q4 		$18.1K Sell
4,853
-236
-5% -$557 ﹤0.01% 5545
2023
Q3 		$10.8K Sell
5,089
-1,256
-20% -$4.16K ﹤0.01% 5878
2023
Q2 		$30.3K Sell
6,345
-219
-3% -$1.21K ﹤0.01% 5284
2023
Q1 		$37.3K Buy
6,564
+193
+3% +$1.17K ﹤0.01% 5158
2022
Q4 		$63.2K Buy
6,371
+5,344
+520% +$100K ﹤0.01% 4759
2022
Q3 		$22K Buy
1,027
+216
+27% +$6.24K ﹤0.01% 5513
2022
Q2 		$20K Sell
811
-204
-20% -$5.63K ﹤0.01% 5603
2022
Q1 		$401K Buy
1,015
+3
+0.3% +$116 ﹤0.01% 3428
2021
Q4 		$61K Sell
1,012
-565
-36% -$32K ﹤0.01% 4994
2021
Q3 		$94K Sell
1,577
-2,092
-57% -$164K ﹤0.01% 4582
2021
Q2 		$320K Buy
3,669
+2,619
+249% +$211K ﹤0.01% 3451
2021
Q1 		$87K Sell
1,050
-676
-39% -$64.8K ﹤0.01% 4460
2020
Q4 		$158K Sell
1,726
-3,692
-68% -$229K ﹤0.01% 3685
2020
Q3 		$197K Buy
5,418
+484
+10% +$16.9K ﹤0.01% 3270
2020
Q2 		$169K Buy
4,934
+71
+1% +$2.12K ﹤0.01% 3280
2020
Q1 		$117K Buy
+4,863
New +$123K ﹤0.01% 3341

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's FATE Position: Q2 2026 in Review

Osaic Holdings held its Fate Therapeutics (FATE) position steady in Q2 2026 at 645 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #7318.

Osaic Holdings first reported a position in FATE in Q1 2020 and has held it in 26 quarters since. The position peaked at $401K in Q1 2022. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Osaic Holdings held 645 shares of Fate Therapeutics worth $1.74K as of Q2 2026.
  • Osaic Holdings left its Fate Therapeutics share count unchanged in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7318 holding.
  • Osaic Holdings first reported a position in Fate Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Fate Therapeutics position peaked at $401K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.